Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS. Read more about Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS.
Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS. Read more about Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS.
Uncovering mechanisms of hyperexcitability in tauopathies with functional genomics. Read more about Uncovering mechanisms of hyperexcitability in tauopathies with functional genomics.
Exploring selective neuronal vulnerability in Alzheimer’s disease – key pathways are downregulated in vulnerable subpopulations of RORB and CDH9 excitatory neurons of the entorhinal cortex at Braak 0. Read more about Exploring selective neuronal vulnerability in Alzheimer’s disease – key pathways are downregulated in vulnerable subpopulations of RORB and CDH9 excitatory neurons of the entorhinal cortex at Braak 0.
Truncated tau accumulates before hyperphosphorylated tau and in relatively distinct neuronal subpopulations in entorhinal cortex and inferior temporal gyrus in Alzheimer’s disease patients. Read more about Truncated tau accumulates before hyperphosphorylated tau and in relatively distinct neuronal subpopulations in entorhinal cortex and inferior temporal gyrus in Alzheimer’s disease patients.
D13 caspase-6-cleaved tau, a new biomarker to complement Alzheimer’s disease diagnosis. Read more about D13 caspase-6-cleaved tau, a new biomarker to complement Alzheimer’s disease diagnosis.
Effective strategies to recruit rural family/friend caregivers of persons living with dementia in the United States into a national randomized controlled trial: preliminary results. Read more about Effective strategies to recruit rural family/friend caregivers of persons living with dementia in the United States into a national randomized controlled trial: preliminary results.
Phospholipase D3 drives microglial response to amyloid pathology in Alzheimer’s disease. Read more about Phospholipase D3 drives microglial response to amyloid pathology in Alzheimer’s disease.
Multiomics of iPSC-derived ApoE3- and ApoE4 astrocytes and microglia uncovers cell type specific dysregulation of immunometabolism. Read more about Multiomics of iPSC-derived ApoE3- and ApoE4 astrocytes and microglia uncovers cell type specific dysregulation of immunometabolism.
Alzheimer’s disease risk genes modulate interferon-responsive microglia. Read more about Alzheimer’s disease risk genes modulate interferon-responsive microglia.
